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A sensitive fluorometric assay for glucocerebroside /J- 
glucosidase [Dinur, T., Grabowski, G.A., Desnick, R.J., and 
Gatt, S. (1984) AnaL Biochent 136, 223-234] has been reex- 
amined. It was found that the lipids containing the NBD 
moiety (12- [N-methyl-N~7-nitrobenz-2~xa-l,3-diazol-t-yl)] 
used for standardization of the assay are l ight~ensitive 
and that the yield of fluorescent light is very sensitive to 
the composition of the solvent used in the fluorometric 
measurement. Some protection against fading could be o1> 
tained by adding a free-radical trapping agent, SlowFade. 
The fading of the free NBD-acid, when used for stan- 
dardization, could be prevented by adding ethanol to the 
solvent, but this reduced the fluorescence yield. It is recom- 
mended that some of the fluorescent substrate be en- 
zymatically hydrolyzed completely to NBD-ceramide, 
which can be utilized as the standard without the need to 
add ethanol. A warning about enzyme reaction rate stabili- 
ty  with time is given, with a suggestion for ensuring con- 
stancy of activity. 
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A simple, sensitive and useful method for the assay of 
glucosylceramide /~-glucosidase (EC 2.3.2.45) has been 
described (1,2), in which a fluorescent analog of glucosyl- 
ceramide (NBD-GlcCer) is used as the substrate and the 
fluorescent enzyme product (NBD-ceramide) is separated 
from the substrate by liquid/liquid partitioning. While other 
useful methods are also available, this one has the advant- 
ages of simplicity, commercial availability of the substrate 
and elimination of the need for radioactivity. However, there 
is a problem in converting the fluorescence readings to molar 
amounts, since the substrate is not soluble in the solvent 
used for reading. The authors (2) suggest that  a standard 
solution of NBD-ceramide or NBD-dodecanoic acid be 
used insteacL 
Two solvent partitioning steps are used to isolate the pr~  
duct of enzyme actiorL The first involves the incubation mix- 
ture (0.45 mL of water), 0.45 mL of isopropyl alcohol, and 
1.5 mL of heptane NBD-ceramide enters the upper phase, 
together with a little of the substrate; the latter is removed 
by transferring most of the upper phase, possibly 1.4 mL, 
and partitioning it against 0.35 mL of water. The first up- 
per phase (called "theoretical upper phase", TUP) differs in 
composition from the second, final upper phase (FUP). 
The earlier authors (2) calculated the amount of enzy- 
matically-formed ceramide by measuring the fluorescence 
of a known amount of NBD<eramide or NBD-acid in the 
first upper phase, although FUP is the solvent actually 
used in the fluoremetric measurement. The statement is 
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Abbreviations: FUP, final upper phase; GlcCer, glucosylceramide; 
NBD-acid, 12- [N-methyl-N-I7-nitrobenz-2-oxa-1,3-diazol-4-yl}] aminc~ 
dodecanoic acid; NBD-GlcCer, the cerebroside made by acylating 
glucosylsphingosine with NBD-acid; TUP, theoretical upper phase. 
made that  the two compounds yield the same molar fluo~ 
escence values. 
No comment was offered about the possible bleaching by 
light of the NBD compounds during handling and reading, 
although fluorescent compounds are notorious for fading 
under some conditions. 
In our utilization of the NBD method, we found some 
discrepancies that  led us to investigate the method in more 
detail This note describes changes in the procedure that im- 
prove the reliability of the method. 
MATERIALS AND METHODS 
NBD-GlcCer, NBD-dodecanoic acid, mixed ceramides 
{Type III) from brain sphingomyelin, and Na taurocholate 
were from Sigma Chemical Co. (St. Louis, MO). SlowFade 
was from Molecular Probes, Eugene, OR (gift of Elizabeth 
Marcus}. GlcCer was prepared from a Gaucher spleen (3). 
Homogenized Madin-Darby canine kidney cells were 
used as the glucosidase source. The substrate emulsion 
in Triton X-100 + Na taurocholate and the incubation 
mixture were prepared as described (2), and the resultant  
fluorescent ceramide was assayed as described in a 1-mL 
cuvet in a Perkin-Elmer {Norwalk, CT) Luminescence 
Spectrometer LS-5B, with excitation at 460 nm and emis- 
sion at 515 nm. A relatively large batch of NBD-ceramide 
was prepared by scaling up the s tandard incubation and 
part i t ioning procedures, using a 20-h incubation at 37 ~ 
to hydrolyze all of the substra t~ 
By similar scaling up, TU P  was prepared with water, 
isopropyl alcohol and heptane (15:15:50, vol/vol/vol) in a 
separatory funnel. F U P  was prepared from the upper 
layer. 
RESULTS 
Portions of 2 ~M NBD-acid in F U P  were stored under 
fluorescent laboratory light for 10, 40 and 70 min, yield- 
ing readings of 90, 70 and 57 units, respectively. Similar 
instability was found also with more dilute solutions. Thus 
it  was evident tha t  the acid was unstable in light after 
final partitioning. When NBD-acid was stored under the 
same conditions in absolute ethanol-FUP solutions, all the 
solutions were stable to light even with as little as 10% 
ethanol. The wavelengths of maximal excitation and emis- 
sion in 100% ethanol were shifted to 475 and 535 nm, and 
there was a small loss of fluorescence yield (74 units for 
2/~M acid}. 
Fur ther  s tudy  with 190 nM NBD-acid in tes t  tubes 
stored 15 to 120 min in F U P  or FUP/EtOH (90:10 vol/vol) 
showed tha t  the readings with F U P  could be brought  up 
to the FUP/EtOH readings by adding the E t O H  just  
before the readings were m ad e  For example, NBD-acid 
stored in the dark for 15 min in F U P  yielded 19 units, 
stored in FUP/EtOH they yielded 56 units  and the addi- 
t ion of E t O H  to F U P  solutions yielded 55 units. Under 
these conditions, it appears tha t  the NBD-acid solution, 
if used as a standard, should contain ethanol. 
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The fluorometric readings, with 462/523 nm settings in 
the fluorometer and NBD-acid in FUI~EtOH (90:10), were 
proportional to concentration between 25 and 400 nM, 
with the extrapolated line passing through the origin. At 
the 400 nM level, omitting the ethanol yielded a reading 
78% lower. 
Study of 100 nM NBD-ceramide in FUP or FUI~EtOH 
showed a somewhat different relationship. The ceramide 
in FUP, read at 515 nm, yielded 96.5, 101.5 and 103.5 
fluorescence units after 15, 60 and 120 rain of exposure 
to ambient fluorescent light, respectively. However, in 
FUI~EtOH (90:10, vol/vol), read at 523 nm, ceramide 
yielded much lower values: 38.1, 39.8 and 40.0 units for 
the same time periods. Thus, while ethanol stabilized the 
readings over time here too, it quenched the fluorescence 
from ceramide" Both solvents yielded readings that were 
proportional to ceramide concentration between 50 and 
250 nM. 
SlowFade, a proprietary free-radical scavenger solution, 
was tested to see if it exerted a stabilizing action. The 
reagent was included in the aqueous phase, using 5.6% 
of the total water, and the first upper phase was then 
prepared by adding heptane and isopropyl alcohol. FUP 
was prepared from this TUP and a 1-mL portion of each 
solution was added to 190 pmol of NBD-ceramide or acid. 
The readings, made after 30 re_in storage in ambient light 
(Table 1), showed, first, that  there was a great difference 
in fluorescence when the two upper phases were compared, 
especially with NBD-ceramide" Second, the two fluores- 
cent compounds responded differently to the two solvents. 
Third, SlowFade was only slightly useful in the case of 
ceramide (11% more fluorescence). Inclusion of SlowFade 
in the incubation system interfered with glucosidase 
activity. 
The difference between the two fluorescent compounds 
with regard to the effect of the second partitioning step 
(decreased fluorescence with the acid v s .  increased 
fluorescence with ceramide) is probably due to dimeriza- 
tion of the acid in the less polar FUP, and consequent 
self-quenching. 
A point which does not seem to have been considered 
before is the possibility that  the fluorescent yields might 
be affected by the detergents in the enzyme incubation 
solutions. We prepared TUP and FUP using an equeous 
system similar to the enzyme medium (Triton X-100 and 
Na taurocholate in phosphate-citrate buffer), as well as 
plain water. Results similar to those in Table 1 were ob- 
tained, and the detergents were found to make no signifi- 
cant difference in the readings with NBD-ceramide or 
NBD-acid. In this experiment, a slight amount of self- 
quenching was found with 250 nM ceramide and much 
more with the acid (i.e.,  the reading with 250 nM NBD- 
acid in FUP was only 2.3 times the reading with 50 nM 
acid). 
Another question needing study was the possibility 
that the presence of ceramide in the incubation system 
(due to enzyme action} affects the partition constant of 
the still-unhydrolyzed GlcCer. A test with the standard 
assay mixture (2), containing NBD-GIcCer and nonfluores- 
cent GlcCer, was compared with the same mixture con- 
taining also 5 ~g of ceramide" The readings obtained in 
the resultant FUP were very low and similar in the two 
samples. Evidently the two lipids do not form an extrac- 
table complex under these conditions. 
TABLE 1 
Effect  of an Anti-Fade Reagent on the Fluorescence of N BD Lipids 
in the Upper Phases  Obtained by the Two Partitioning Steps 
in NBD-Ceramide Isolation a 
Fluorescence intensity at 515 nm 
NBD-dodecanoic 
NBD-ceramide acid Solvent 
SlowFade present No Yes No Yes 
First upper phase 88 100 75 75 
Final upper phase 203 225 45 42 
aThe values shown are the means of duplicates. 
DISCUSSION 
In view of the difficulty of making an accurate comparison 
between free NBD-acid and NBD-ceramide molar light 
yields, and the incomplete constancy of the fluorescence/ 
concentration ratio of the acid, it is preferable to use the 
ceramide as the standard. Because of the high cost of the 
ceramide, and since only a small amount of NBD-ceramide 
is needed to standardize each set of assays, it is much more 
economical to make it enzymatically from the substrate" 
f~Glucosidase, in the form of crude lysosomes, is readily 
prepared from any tissue by differential centrifugation. 
We incubated NBD-GlcCer at 37 ~ C overnight in the stan- 
dard incubation medium (2) and then isolated the product 
by partitioning in the usual way between heptane, iso- 
propyl alcohol, and water. It  is not necessary to purify the 
NBD-ceramide further since the background fluorescence 
from the reagents and enzyme is negligible. A thin-layer 
chromatogram of the material in the FUP, with a silica 
gel plate and chloroform/HOAc (90:10, vol/vol), examined 
under ultraviolet light, showed virtually complete conver- 
sion of the substrate, with just a trace of free NBD-acid. 
The concentrations of stock substrate and product solu- 
tions were determined by measuring at ~ = 475 nm, rather 
than at 485. 
In summary, our recommended changes in the pro- 
cedure are (i) to make and use NBD-ceramide as the molar 
standard rather than NBD-acid, (ii) to standardize the 
assay with NBD-ceramide in FUP, not in TUP, and (iii) 
to handle the samples in reduced light as much as possi- 
ble. Moreover, the sensitivity of the fluorescence yield to 
solvent composition emphasizes the need to do the parti- 
tioning and upper phase transfer with maximal 
reproducibility, preferably with a suction transfer device. 
A weakness in the published method (2) is that the reac- 
tion rate, using human granulocyte extracts, was not con- 
stant over time. The initial rate was relatively high, then 
it slowed down and became constant after the first 30 min. 
This makes it difficult to calculate Km and Vm~x values 
accurately. While it might be satisfactory to use short in- 
cubation times, when the linearity problem is not so 
severe, this weakens the sensitivity of the assay, since 
much higher readings can be obtained at the cost only 
of some patience. Another approach, also unsatisfactory, 
is to double the number of assay tubes and measure the 
amount of ceramide formed at the 30-min point and at 
a somewhat later point. 
Perhaps an explanation for the changing velocities lies 
in a report that  the human spleen contains two different 
GlcCer glucosidases (4). Later study (5) showed that  one 
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form could be converted into the other, so it is posssible 
that  the conversion occurs during incubation and that  the 
final equilibrium mixture of enzymes is less active than 
its initial mixture. An early s tudy in the laboratory of the 
senior author (NSR) yielded a very similar biphasic veloci- 
ty  activity curve with ~-glucosidase from human placen- 
ta; preincubation with taurocholate eliminated the first 
velocity phase (6). Thus systems showing a biphasic time 
course should be tested with a preincubation protocol. 
A s tudy of the literature discloses several papers tha t  
give Km and Vm~ values for this enzyme but  very few of 
these make the claim tha t  the reaction velocity was con- 
stant. Using Madin-Darby canine kidney cells, we found 
the rate was constant  over time at all time points studied 
(5 to 60 rain) with a K m of 0.20 mM. Similar constancy 
was reported for porcine epidermis (7), mouse kidney (8), 
and purified enzyme from ox brain {9). Glucosidase from 
human tissues was said to yield constant  activities in the 
case of placenta {10) and, for at least 60 min, with spleen 
membranes (11), and for 6 h with skin fibroblasts {12}. At 
present, we can only urge investigators measuring /~- 
glucosidase to check their velocity constancy. 
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